Cardiovascular Systems Inc (CSI), a subsidiary of Abbott Laboratories, is a medical device company that develops and commercializes products for the treatment of peripheral and coronary vascular disease. The company's products include peripheral orbital atherectomy systems, coronary orbital atherectomy systems, crowns, and accessories. Its peripheral artery disease system is a percutaneous orbital atherectomy system that is used as therapy for OAS atherosclerotic disease in peripheral arteries. CSI offers accessories such as guide wires, lubricants, infusion pumps and ancillary products. It has developed orbital atherectomy systems technology for both peripheral and coronary commercial applications. The company serves patients suffering from peripheral arterial disease and coronary artery diseases. It markets its products through its network of distributors in the US to hospitals and clinics. CSI is headquartered in St. Paul, Minnesota, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Cardiovascular Systems Inc
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company
Cardiovascular Systems Inc Company Overview
Cardiovascular Systems Inc Company Snapshot
Cardiovascular Systems Inc Pipeline Products and Ongoing Clinical Trials Overview
Cardiovascular Systems Inc – Pipeline Analysis Overview
Cardiovascular Systems Inc - Key Facts
Cardiovascular Systems Inc - Major Products and Services
Cardiovascular Systems Inc Pipeline Products by Development Stage
Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status
Cardiovascular Systems Inc Pipeline Products Overview
Cardiovascular Systems Inc - Locations And Subsidiaries
Head Office
Recent Developments
Cardiovascular Systems Inc, Recent Developments
Oct 12, 2022: Cardiovascular Systems to Host Earnings Conference Call on November 3, 2022
Feb 24, 2022: Cardiovascular Systems and Innova Vascular partner on thrombectomy devices
Jan 13, 2022: Cardiovascular Systems announces development of intravascular lithotripsy technology for the treatment of coronary and peripheral artery diseases
Jul 27, 2021: Cardiovascular Systems to Attend Three Investor Conferences in August
Mar 24, 2021: Cardiovascular Systems to Participate at the 20th Annual Needham Healthcare Conference
Feb 03, 2021: Cardiovascular Systems, Inc. Reports Fiscal 2021 Second-quarter Financial Results
Feb 01, 2021: Cardiovascular Systems announces partnership with Chansu Vascular to develop new drug-coated balloon technology
Oct 21, 2020: Cardiovascular Systems, Inc. to Webcast Fiscal 2021 First-Quarter Earnings Conference Call Wednesday, November 4
Jul 14, 2020: Cardiovascular Systems, Inc. to Webcast Fiscal 2020 Fourth-Quarter Earnings Conference Call Tuesday, August 4
Dec 16, 2019: Cardiovascular Systems, introduces peripheral orbital atherectomy system with GlideAssist in Europe
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Cardiovascular Systems Inc Pipeline Products and Ongoing Clinical Trials Overview
Cardiovascular Systems Inc Pipeline Products by Equipment Type
Cardiovascular Systems Inc Pipeline Products by Indication
Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status
Cardiovascular Systems Inc, Key Facts
Cardiovascular Systems Inc, Major Products and Services
Cardiovascular Systems Inc Number of Pipeline Products by Development Stage
Cardiovascular Systems Inc Pipeline Products Summary by Development Stage
Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status
Cardiovascular Systems Inc Ongoing Clinical Trials Summary
Antegrade/Retrograde Microcatheter - Product Status